Esophageal and Gastroesophageal Junction Carcinoma

Esophageal and Gastroesophageal Junction Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,309 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 460
Recruiting: 254
Ph III recruiting: 40
Growth YoY: +36.1%
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (120)

clinicaltrialsPublishedShowing 151–200 of 550 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07697859	PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC(ESO-shanghai31)	recruiting	—	354	Fudan UniversityOTHER	1	Jul 13, 2026	clinicaltrials
NCT07697898	TDLN-Guided Lymphadenectomy After Neoadjuvant Immunochemotherapy for ESCC	not yet recruiting	—	400	Tongji HospitalOTHER	0	Jul 13, 2026